PsychoGenics Inc. Obtains an Exclusive License to the APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease
8/21/2013 9:28:58 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TARRYTOWN, N.Y.--(BUSINESS WIRE)--PsychoGenics announced today that it has obtained an exclusive license from the University of South Florida to its APP/PS1 double transgenic mice (US Patent No. 5,898,094), co-expressing the M146L presenilin 1(PS1) mutation and the double mutations at K670N/M671L (Swedish mutation) in the amyloid precursor protein (APP).
Help employers find you! Check out all the jobs and post your resume.
comments powered by